MBCL-34. EFFICACY OF METHOTREXATE (MTX) ACCORDING TO MOLECULAR SUB-TYPE IN YOUNG CHILDREN WITH MEDULLOBLASTOMA (MB): A REPORT FROM CHILDREN’S ONCOLOGY GROUP PHASE III TRIAL ACNS0334

ACNS0334, a Phase 3 trial, compared outcomes of children <36 months treated with intensive chemotherapy +/-high-dose methotrexate. Nodular-desmoplastic M0-stage MB were excluded. Treatment included 3 induction cycles (cyclophosphamide/etoposide/vincristine/cisplatin+/-mtx) and 3 consolidation cyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazewski, Claire, Kang, Guolian, Kellie, Stewart, Gossett, Jeffrey, Leary, Sarah, Li, Bryan, Aridgides, Paul, Hayes, Laura, Reddy, Alyssa, Shaw, Dennis, Burger, Peter, Judkins, Alexander, Geyer, Jeffrey Russell, Fouladi, Maryam, Huang, Annie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715297/
http://dx.doi.org/10.1093/neuonc/noaa222.510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715297/
http://dx.doi.org/10.1093/neuonc/noaa222.510

Ejemplares similares